Clinical Trial Update: ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial of ELVN-001 in Japanese participants with chronic myeloid leukemia (with or without the T315I mutation) is currently recruiting to evaluate safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• ELVN-001

Snippet

Sponsor: Enliven Therapeutics | Conditions: CML (Chronic Myelogenous Leukemia), Chronic Phase CML | Phase 1 | Status: RECRUITING